Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A12 | P48065 | 5/20 | 0.37 |
| ▸ | SLC6A11 | P48066 | 5/20 | 0.37 |
| ▸ | SLC6A13 | Q9NSD5 | 5/20 | 0.37 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10248675 | 0.83 | ALDH1A1 (0.37) | ALDH1A1GAADPP4TSHR | |
| SCHEMBL28513346 | 0.81 | SLC6A12 (0.50) | SLC6A12SLC6A11SLC6A13SLC6A1GABRA5 | |
| SCHEMBL10248640 | 0.80 | ALDH1A1 (0.33) | SLC6A12SLC6A11SLC6A13SLC6A1GABRA5 | |
| SCHEMBL10248670 | 0.78 | SLC6A12 (0.37) | SLC6A12SLC6A11SLC6A13SLC6A1GABRA5 | |
| SCHEMBL16399328 | 0.77 | — | — | |
| SCHEMBL10248709 | 0.75 | ALDH1A1 (0.44) | SLC6A12SLC6A11SLC6A13SLC6A1GABRA5 | |
| SCHEMBL25975361 | 0.74 | DPP4 (0.34) | ALDH1A1GAADPP4LTA4H | |
| SCHEMBL16055768 | 0.73 | KMT2A (0.42) | ALDH1A1GAAPOLBDPP4LTA4H | |
| SCHEMBL20572677 | 0.72 | SLC6A12 (0.42) | SLC6A12SLC6A11SLC6A13SLC6A1GABRA5 | |
| SCHEMBL20572678 | 0.72 | SLC6A12 (0.42) | SLC6A12SLC6A11SLC6A13SLC6A1GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127451-A1 | SUBSTITUTED PURINE COMPOUNDS | Epizyme, Inc. | 2018-05-10 | — | — | US | disclosed |
| US-9688714-B2 | Substituted purine compounds | Epizyme, Inc. (US) | 2017-06-27 | — | — | US | disclosed |
| US-20160368943-A1 | SUBSTITUTED PURINE COMPOUNDS | Epizyme, Inc. | 2016-12-22 | — | — | US | disclosed |
| US-9096634-B2 | Substituted purine and 7-deazapurine compounds | Epizyme, Inc. (US) | 2015-08-04 | — | — | US | disclosed |
| US-20140051654-A1 | Substituted Purine and 7-Deazapurine Compounds | Epizyme, Inc. (US) | 2014-02-20 | — | — | US | disclosed |
| US-8580762-B2 | Substituted purine and 7-deazapurine compounds | Epizyme, Inc. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20120142625-A1 | Substituted Purine And 7-Deazapurine Compounds | Epizyme, Inc. (US) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051654-A1 | Substituted Purine and 7-Deazapurine Compounds | TPMT, DIMT1, DAZAP1 | SLC6A12 4124/4885SLC6A11 2873/4885SLC6A13 3789/4885 |
| US-20160368943-A1 | SUBSTITUTED PURINE COMPOUNDS | DIMT1, DOT1L, TPMT | SLC6A12 4054/4885SLC6A11 3616/4885SLC6A13 4353/4885 |
| US-20180127451-A1 | SUBSTITUTED PURINE COMPOUNDS | DIMT1, DOT1L, TPMT | SLC6A12 4054/4885SLC6A11 3616/4885SLC6A13 4353/4885 |
| US-20120142625-A1 | Substituted Purine And 7-Deazapurine Compounds | TPMT, DIMT1, DAZAP1 | SLC6A12 4124/4885SLC6A11 2873/4885SLC6A13 3789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.